240 results on '"Woolbright, Benjamin L."'
Search Results
2. Aging induces changes in cancer formation and microbial content in a murine model of bladder cancer
3. Bladder cancer, inflammageing and microbiomes
4. Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials
5. Inflammation: Cause or consequence of chronic cholestatic liver injury
6. Mice deficient in pyruvate dehydrogenase kinase 4 are protected against acetaminophen-induced hepatotoxicity
7. Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes
8. Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex
9. Metabolic changes in bladder cancer
10. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
11. Mechanistic Biomarkers in Liver Diseases
12. Mechanisms of Acetaminophen-Induced Liver Injury
13. Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity
14. Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure
15. Direct Amplification of Tissue Factor: Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation
16. Microcystin-LR induced liver injury in mice and in primary human hepatocytes is caused by oncotic necrosis
17. Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity
18. Mechanisms of Inflammatory Liver Injury and Drug-Induced Hepatotoxicity
19. Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL/6 mice: 6N versus 6J
20. Caspase Inhibition Prevents Tumor Necrosis Factor-α–Induced Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes in Vivo and in Vitro
21. Measuring Apoptosis and Necrosis in Cholestatic Liver Injury
22. Molecular subtyping of bladder cancer: current trends and future directions in 2019
23. Abstract 2119: Intravenous vitamin C therapy for cisplatin ineligible bladder cancer patients (CI-MIBC): Early investigation into potential pharmacodynamic biomarkers
24. Figure S3 from The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
25. Supplementary Table 1 from The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
26. Data from The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
27. Pyruvate Dehydrogenase Kinase 4 Deficiency Increases Tumorigenesis in a Murine Model of Bladder Cancer
28. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis
29. Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy
30. Biomarkers of Mitochondrial Injury After Acetaminophen Overdose
31. Role of MIF1 / MIF2 / CD74 interactions in bladder cancer
32. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice
33. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice
34. SATB1 and bladder cancer: Is there a functional link?
35. Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis
36. Current strategies to minimize hepatic ischemia–reperfusion injury by targeting reactive oxygen species
37. Generation of pro-and anti-inflammatory mediators after acetaminophen overdose in surviving and non-surviving patients
38. Abstract 3991: Ts65Dn Down syndrome mice reveal a potential therapeutic vulnerability in a BBN bladder cancer model and subset of bladder cancer cell lines
39. Abstract 224: Effect of Agent Orange and Agent Blue derived carcinogens on bladder cancer cell lines and a murine bladder cancer model
40. IV vitamin C with chemotherapy for cisplatin ineligible bladder cancer patients (CI-MIBC) first-stage analysis NCT04046094.
41. Fosciclopirox clinical proof of concept in patients with nonmuscle invasive and muscle-invasive bladder cancer.
42. Mechanistic Biomarkers in Liver Diseases
43. Neurologic cues modulate immune-mediated liver injury and regeneration
44. Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes
45. Role of MIF1/MIF2/CD74 interactions in bladder cancer.
46. Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the Liver
47. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro
48. Specific regulation of CYP27B1 and VDR in proximal versus distal renal cells
49. Glycodeoxycholic Acid Levels as Prognostic Biomarker in Acetaminophen-Induced Acute Liver Failure Patients
50. Abstract 2911: Intersection of aging, the microbiome and inflammation in a mouse model of bladder cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.